Immune Checkpoint Inhibitors in Melanoma of Unknown Primary

被引:0
|
作者
Ho, F. [1 ]
Torphy, R. J. [1 ]
Tobin, R. P. [1 ]
Borgers, J. S. [2 ]
Vorwald, V. M. [1 ]
Amato, C. A. [3 ]
Van Gulick, R. [3 ]
Cogswell, D. T. [1 ]
Gonzalez, R. [3 ]
Lewis, K. D. [3 ]
Medina, T. M. [3 ]
Rioth, M. J. [3 ]
Gleisner, A. L. [1 ]
Robinson, W. A. [3 ]
McCarter, M. [1 ]
机构
[1] Univ Colorado, Dept Surg, Aurora, CO USA
[2] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[3] Univ Colorado, Dept Med Oncol, Aurora, CO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P166
引用
收藏
页码:S105 / S106
页数:2
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in patients with cancers of unknown primary
    Rassy, Elie
    Karam, Elias
    Adeleke, Sola
    Okoli, Somto
    Galante, Joao
    Boussios, Stergios
    Pavlidis, Nicholas
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [2] Mechanisms of primary resistance to immune checkpoint inhibitors in Melanoma
    Moogk, Duane
    Wang, Lin
    Li, Kaitao
    Yuan, Zhou
    Zhong, Shi
    Yu, Zhiya
    Liadi, Ivan
    Rittase, William
    Fang, Victoria
    Dougherty, Janna
    Perez-Garcia, Arianne
    Varadarajan, Navin
    Restifo, Nicholas P.
    Frey, Alan
    Osman, Iman
    Weber, Jeff
    Zhu, Cheng
    Krogsgaard, Michelle
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [3] Melanoma and Immune Checkpoint Inhibitors
    Masutaka Furue
    Takamichi Ito
    Naoko Wada
    Maiko Wada
    Takafumi Kadono
    Hiroshi Uchi
    Current Oncology Reports, 2018, 20
  • [4] Immune checkpoint inhibitors in melanoma
    Carlino, Matteo S.
    Larkin, James
    Long, Georgina V.
    LANCET, 2021, 398 (10304): : 1002 - 1014
  • [5] Immune checkpoint inhibitors in melanoma
    Cooper, Adam J.
    Carlino, Matteo S.
    Kefford, Richard F.
    MELANOMA MANAGEMENT, 2015, 2 (03) : 267 - 284
  • [6] Melanoma and Immune Checkpoint Inhibitors
    Furue, Masutaka
    Ito, Takamichi
    Wada, Naoko
    Wada, Maiko
    Kadono, Takafumi
    Uchi, Hiroshi
    CURRENT ONCOLOGY REPORTS, 2018, 20 (03)
  • [7] Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Gide, Tuba N.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1260 - 1270
  • [8] Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?
    Kourie, Hampig Raphael
    Awada, Gil
    Awada, Ahmad Hussein
    FUTURE ONCOLOGY, 2016, 12 (04) : 429 - 431
  • [9] Primary resistance to immune-checkpoint inhibitors in patients with metastatic melanoma
    Amaral, Teresa
    Assi, Zeinab
    Keim, Ulrike
    Meiwes, Andreas
    Thomas, Ioannis
    Wilhelmi, Julia
    Eigentler, Thomas
    Garbe, Claus
    Seeber, Olivia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [10] Immune checkpoint inhibitors for the treatment of melanoma
    Sabbatino, Francesco
    Liguori, Luigi
    Pepe, Stefano
    Ferrone, Soldano
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 563 - 576